Free Trial

Nova (NVMI) Competitors

Nova logo
$190.41 +2.08 (+1.10%)
(As of 12/16/2024 ET)

NVMI vs. TER, AVTR, RVTY, BIO.B, VNT, ST, MIR, TRNS, CTKB, and LAB

Should you be buying Nova stock or one of its competitors? The main competitors of Nova include Teradyne (TER), Avantor (AVTR), Revvity (RVTY), Bio-Rad Laboratories (BIO.B), Vontier (VNT), Sensata Technologies (ST), Mirion Technologies (MIR), Transcat (TRNS), Cytek Biosciences (CTKB), and Standard BioTools (LAB). These companies are all part of the "measuring and control equipment" industry.

Nova vs.

Nova (NASDAQ:NVMI) and Teradyne (NASDAQ:TER) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, earnings, community ranking, media sentiment, valuation, dividends, profitability, risk and analyst recommendations.

Nova has a beta of 1.44, indicating that its stock price is 44% more volatile than the S&P 500. Comparatively, Teradyne has a beta of 1.51, indicating that its stock price is 51% more volatile than the S&P 500.

Nova received 379 more outperform votes than Teradyne when rated by MarketBeat users. Likewise, 74.30% of users gave Nova an outperform vote while only 44.23% of users gave Teradyne an outperform vote.

CompanyUnderperformOutperform
NovaOutperform Votes
448
74.30%
Underperform Votes
155
25.70%
TeradyneOutperform Votes
69
44.23%
Underperform Votes
87
55.77%

83.0% of Nova shares are held by institutional investors. Comparatively, 99.8% of Teradyne shares are held by institutional investors. 1.0% of Nova shares are held by company insiders. Comparatively, 0.4% of Teradyne shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Nova presently has a consensus target price of $227.80, suggesting a potential upside of 19.64%. Teradyne has a consensus target price of $147.25, suggesting a potential upside of 13.72%. Given Nova's higher probable upside, equities research analysts plainly believe Nova is more favorable than Teradyne.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Nova
0 Sell rating(s)
2 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.67
Teradyne
0 Sell rating(s)
4 Hold rating(s)
9 Buy rating(s)
0 Strong Buy rating(s)
2.69

Nova has a net margin of 28.00% compared to Teradyne's net margin of 18.75%. Nova's return on equity of 21.35% beat Teradyne's return on equity.

Company Net Margins Return on Equity Return on Assets
Nova28.00% 21.35% 14.34%
Teradyne 18.75%18.56%13.91%

Teradyne has higher revenue and earnings than Nova. Nova is trading at a lower price-to-earnings ratio than Teradyne, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Nova$611.85M9.04$136.31M$5.3635.52
Teradyne$2.68B7.88$448.75M$3.1541.10

In the previous week, Teradyne had 17 more articles in the media than Nova. MarketBeat recorded 23 mentions for Teradyne and 6 mentions for Nova. Nova's average media sentiment score of 1.41 beat Teradyne's score of 1.13 indicating that Nova is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Nova
4 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Teradyne
12 Very Positive mention(s)
3 Positive mention(s)
4 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Nova beats Teradyne on 10 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

NVMI vs. The Competition

MetricNovaOptical instruments & lenses IndustryComputer SectorNASDAQ Exchange
Market Cap$5.53B$14.44B$24.73B$9.29B
Dividend YieldN/A1.43%2.66%4.01%
P/E Ratio35.5222.53269.8517.26
Price / Sales9.045.183,545.1582.57
Price / Cash35.9220.9033.5438.32
Price / Book7.367.348.074.91
Net Income$136.31M$354.61M$656.03M$224.23M
7 Day Performance-4.08%17.67%0.13%0.73%
1 Month Performance6.57%18.32%10.05%8.07%
1 Year Performance43.81%43.34%26.24%24.20%

Nova Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
NVMI
Nova
3.2771 of 5 stars
$190.41
+1.1%
$227.80
+19.6%
+42.2%$5.53B$611.85M35.523,606Positive News
TER
Teradyne
4.8896 of 5 stars
$120.73
+1.9%
$142.62
+18.1%
+17.2%$19.66B$2.68B37.626,500Analyst Upgrade
Short Interest ↑
News Coverage
Positive News
Gap Up
AVTR
Avantor
4.8112 of 5 stars
$22.20
+3.8%
$27.69
+24.7%
-2.9%$15.11B$6.97B46.5014,500Short Interest ↓
Analyst Revision
Positive News
RVTY
Revvity
3.9746 of 5 stars
$120.09
+3.1%
$131.73
+9.7%
+14.6%$14.61B$2.75B56.2611,500Analyst Upgrade
Positive News
BIO.B
Bio-Rad Laboratories
N/A$337.08
flat
N/A+10.2%$9.44B$2.67B0.008,200
VNT
Vontier
3.3651 of 5 stars
$39.04
+1.0%
$44.50
+14.0%
+13.4%$5.86B$2.99B14.928,000Short Interest ↑
Positive News
ST
Sensata Technologies
4.7008 of 5 stars
$31.04
+1.4%
$41.00
+32.1%
-15.7%$4.64B$4.05B0.0019,400
MIR
Mirion Technologies
2.5958 of 5 stars
$18.23
+0.6%
$16.67
-8.6%
+78.2%$4.23B$800.90M0.003,000Positive News
TRNS
Transcat
3.0504 of 5 stars
$103.52
+1.4%
$127.25
+22.9%
+7.4%$952.38M$259.48M51.551,104Positive News
CTKB
Cytek Biosciences
2.5486 of 5 stars
$6.76
+4.5%
$9.17
+35.6%
-31.6%$870.76M$193.01M0.00500Positive News
LAB
Standard BioTools
3.2174 of 5 stars
$1.93
+6.0%
$2.88
+49.0%
-4.0%$718.46M$106.34M0.00620

Related Companies and Tools


This page (NASDAQ:NVMI) was last updated on 12/16/2024 by MarketBeat.com Staff
From Our Partners